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the control group (P>0.05); there were signiﬁcant changes in NT-pro
BNP (P<0.05).
4. There were signiﬁcant changes in PaO2 in both groups after the
experiment (P<0.05), there were no signiﬁcant changes in NT-pro
BNP, PH, PaCO2, HCO3-, SaO2 group (P> 0.05).
5. There were no signiﬁcant changes in Naþ, Kþ, Cl-, Ca2þ con-
centration and creatinine.
CONCLUSIONS This study shows that inhaled furosemide for heart
failure patients improve hypoxemia and dyspnea have a role in the
degree of reduction. To reduce cardiac wall tension, decreased plasma
levels of NT-pro BNP is not helpful. Study of inhaled furosemide
serious adverse event occurred, it has a good safety.
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A simple score model to predict 30-day in-hospital mortality in patients
with acute decompensate heart failure at admission only by patients’ age
and comorbidities
Yamin Cao, Yanming Chen, Xingli Wu, Yusheng Zhao
Chinese PLA General Hospital
OBJECTIVES More and more patients with acute decompensate heart
failure(ACHF) appear in hospitals. How to estimate in-hospital mor-
tality and stratify these patients become very important, but simple
and easy to handle approaches are few. The article tried to develop a
practical score model.
METHODS A total of 6,949 patients were identiﬁed from the hospital
database. The patient whose hospital stay was over less than 30-day
were included. The basic characters, all kinds of co-morbidities and all
cause deaths in hospital within 30-day were recorded from the pa-
tients’ medical ﬁle.
All co morbidities that co-existed in patients were collected. Percent-
ages were reported to describe categorical variables, mean  SD to
describe the continuous variables. The variables that associated with 30-
day in-hospital death were pick out by univariate analysis from the
candidate variables, and were included in a multiple logistic regression
model as predicting covariates. Age and nine co morbidities were corre-
lated with the 30-day in-hospital death and became valuable predictors.
Score rulers for the 30-day in-hospital mortality came from logistic
regression by a regression coefﬁcient-based scoring method. A patient 30-
day in-hospital death risk could be estimated by his general score which
could be gotten by summing the score of each predictor the patient had.
Categorical variables were compared using the c2 test, and the contin-
uous variables were compared among the 5 groups using 1-way analysis
of variance followed by the post hoc Bonferroni multiple comparisons
test. The discrimination of this model was valued by the area under
receiver operator characteristic curve (AUC). All statistical tests were
performed using SPSS 16.0 for Windows (SPSS Inc., Chicago, Inc.).
RESULTS 6,949 patients were included. There were totally 19
comorbidities were collected. The 30-day in-hospital mortality of
patients with ADHF was 5.4%. There are nine comorbidities: the
COPD, stroke, renal failure, cirrhosis of liver, myocardial infarction
(MI), pneumonia, gastrointestinal bleeding and multiple organ
dysfunction syndromes (MODS) and age older than 65 years are the
independent risk factors of the 30-day in hospital death. According to
his total score, a patient could be stratiﬁed into very low, low, mod-
erate and high death risk grade.
The power of the score mode was assessed by the area under the
receiver operating characteristic curve (AUC), the AUC of the score is
0.778, 0.122 larger than using comorbidities directly.
CONCLUSIONS By the model the estimation of 30-day in-hospital
mortality in patients with ADHF could be gotten only by patients’ age
and comorbidities at admission at once.
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Study on change in levels of HMGB1, TNF-a, Chemerin in Patients with
Congestive Heart Failure And Its Relationship with ventricular remodeling
Aiqi Xi, Baoxia Liao
the People’s Hospital of Qinghai Province, Xining, Qinghai
OBJECTIVES To study the change of serum high mobility group box 1
protein (HMGB1), tumor necrosis factor-a (TNF-a), Chemerin and its
relationship with ventricular remodeling in patients with congestive
heart failure(CHF).
METHODS A total of 74 consecutive patients with CHF (36 cases of
cardiac function levels II, 38 cases of levels III) and 27 healthy subjects
with matched age and sex were enrolled. The levels of HMGB1,TNF-aand Chemerin were measured by ELISE. Left ventricular ejec-
tion fraction(LVEF) from echocardiography and left ventricular mass
index (LVMI), mean wall stress (MWS) was calculated.
RESULTS LVEF in patients with CHF were lower than that in healthy
subjects (40.2311.56)% vs (68.737.05)%, the levels of HMGB1,
TNF-a, Chemerin and LVMI, MWS were on the contrary [(27.386.81)
pg/ml vs (9.521.82) pg/ml, (86.459.13) ng/L vs (25.265.23) ng/L,
(267.53 31.05) ng/mL vs ( 123.8724.74) ng/mL, (184.412.1 ) vs
(76.98.7)g/m2 and (439.627.9) vs (223.519.7) dynes103/cm2, all
p<0.01 respectively]. With the increase of NYHA and development of
disease, the levels of HMGB1, TNF-a, Chemerin and LVMI, MWS
signiﬁcantly increased; and the levels of HMGB1, TNF-a and Chemerin
were positive correlation with LVMI and MWS (P<0.01). but a negative
correlation with LVEF (P<0.01).
CONCLUSIONS Change of the levels of serum HMGB1, TNF-a, Chemerin
and LVMI, MWS in the patients with CHF can reﬂect impairment of the
cardiac function and the degree of ventricular remodeling. Increasing in
the levels of serum HMGB1, TNF-a, Chemerin and MWS is earlier than the
pathologic structural change of left ventricular remodeling.It is suggested
that change of the levels of HMGB1, TNF-a, Chemerin and LVMI, MWS
play a role in the pathophysiological and pathogenetic mechanism of
chronic heart failure, they may interact and inﬂuence each other and lead
to ventricular remodeling.
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The effect of serum N-terminal pro-brain natriuretic peptide(NT-proBNP)
and QTc interval dispersion in the diagnosis of CHF and evaluation of heart
function
Ruihua Wang, Yanfen Li, Yuhong Huang, Lanjun Sun
The Second Afﬁliated Hospital of Tianjin University of Traditional
Chinese Medicine
OBJECTIVES By observing the relationship between serum N-terminal
pro-brain natriuretic peptide (NT-proBNP) concentration, QTc interval
dispersion (QTcd) and the NYHA heart function classiﬁcation, left ven-
tricular ejection fraction (LVEF), we study the effection of NT-proBNP and
QTcd in the diagnosis of CHF and evaluation of heart function.
METHODS We select 84 hospitalized patients with CHF disease and
60 healthy controls from 2014 March to December in our hospital.The
serum NT-proBNP concentration was measured by immune chem-
iluminescence method.QTc interval was detected by Mortara 12 lead
ECG ELI250, LVEF was determined by America HP5500 type color
echocardiography, heart funtion in patients with CHF was classiﬁed
according to the NYHA.
RESULTS The mean serum NT-proBNP concentration in patients with
CHF (323.3816.41) pg/ml and QTc interval dispersion (42.84 4.16) ms
was signiﬁcantly higher than that in healthy controls (44.876.20) pg/ml,
23.35 3.00) ms, there were statistically differences P <0.01. There was a
positive correlation between serum NT-proBNP concentration and QTc
interval dispersion (r¼0.817, P<0.01). There was a signiﬁcant positive
correlation between NYHA classiﬁcation and NT-pro BNP concentration,
QTc interval dispersion (r¼0.834, P <0.01), (r¼0.830, P<0.01). There was
a signiﬁcant negative correlation between LVEF and NT-proBNP, QTc
interval dispersion (r ¼-0.770, P <0.01), r ¼-0.810, P <0.01). The analysis
of effects of NT-pro BNP, QTcd in the diagnosis of heart failure by
employing the receiver operating characteristic(ROC) curve led to the
result that the area under the curve AUC were 0.806 and 0.712,95%
respectively and conﬁdence interval were 0.737-0.875 and 0.603-0.822,
respectively with the existence of statistical difference. The diagnostic
cutoff value respectively was 128.45pg/ml,42.3ms; the Youden index
which was the highest, respectivelywas 0.807,0.706.
CONCLUSIONS NT-pro BNP and QTc interval dispersion can be
objective and accurate assessment of heart function in patients with
chronic congestive heart failureNT-pro BNP and QTc interval disper-
sion have ideal sensitivity and speciﬁcity in diagnosis of heart failure
NYHA classiﬁcation and left ventricular systolic dysfunction and can
be used as a laboratory marker of clinical diagnosis and heart failure
degree evaluation.
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Based on clinical studies of plasma NT-proBNP for the diagnosis of
diastolic heart failure optimal cutoff value observed
Qixia Heng
Zhongmou County People’s Hospital
OBJECTIVES To investigate the relationship between high blood
pressure in patients with plasma NT-proBNP and diastolic heart
